IOM Plans Study To Facilitate Clinical Trial Data Sharing
This article was originally published in The Gray Sheet
Executive Summary
The Institute of Medicine issued a draft framework for a study on expanding clinical trial data sharing and is seeking input from outside parties. The draft discusses how competing firms, disease advocacy groups and the media might responsibly use data shared by clinical trial sponsors.
You may also be interested in...
JAMA Studies Provide More Ammunition For Trial Disclosure Reformers
JAMA studies focus on the high number of terminated and unreported trials, plus discrepancies in publicly reported trial results. Publication comes as the Institute of Medicine consults stakeholders about trial data sharing and ahead of new reporting laws in Europe.
Researchers Debate Costs Of Clinical Trial Data Sharing At IOM Gathering
The costs associated with more expansive sharing of clinical trial data for independent research would be significant, experts warned at a meeting convened by the Institute of Medicine to help inform a planned study on strategies for increasing trial data-sharing.
J&J Works Toward Device Data-Sharing Agreement Following Pharma Plan
Independent researchers will be able to request access to clinical trial data for any J&J drug from clinicians at Yale’s Open Data Access Project without involvement by the company. J&J is now in discussions to set up a similar arrangement for its device and consumer products trial data.